Envista Holdings's top three insider shareholders as of September 29, 2026 are Paul A Keel (Chief Executive Officer, 551.30K shares), Amir Aghdaei (Chief Executive Officer, 310.56K shares), Eric D. Hammes (Chief Financial Officer, 99.91K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Paul A Keel | Chief Executive Officer | 551,304 | 0 | 551,304 | 26.1% | 20 Aug, 2026 |
| 2 | Amir Aghdaei | Chief Executive Officer | 310,565 | 0 | 310,565 | 14.7% | 27 Feb, 2024 |
| 3 | Eric D. Hammes | Chief Financial Officer | 99,913 | 0 | 99,913 | 4.7% | 27 Aug, 2026 |
| 4 | R Scott Huennekens | Director | 82,105 | 0 | 82,105 | 3.9% | 21 May, 2026 |
| 5 | Mark E Nance | General Counsel | 81,252 | 0 | 81,252 | 3.8% | 27 Feb, 2026 |
| 6 | Barbara B. Hulit | Director | 79,820 | 0 | 79,820 | 3.8% | 12 Jun, 2025 |
| 7 | Patrik Eriksson | Senior Vice President | 79,686 | 0 | 79,686 | 3.8% | 18 Sep, 2023 |
| 8 | Stefan Nilsson | President, Nobel Biocare | 61,560 | 0 | 61,560 | 2.9% | 27 Aug, 2026 |
| 9 | Wendy Carruthers | Director | 59,940 | 0 | 59,940 | 2.8% | 21 May, 2026 |
| 10 | Christine A Tsingos | Director | 59,930 | 0 | 59,930 | 2.8% | 21 May, 2026 |
| 11 | Faez C Kaabi | Chief Accounting Officer | 58,552 | 0 | 58,552 | 2.8% | 27 Feb, 2026 |
| 12 | Kieran Gallahue | Director | 54,010 | 0 | 54,010 | 2.6% | 21 May, 2026 |
| 13 | Daniel Raskas | Director | 54,010 | 0 | 54,010 | 2.6% | 21 May, 2026 |
| 14 | Stephen Keller | Principal Financial Officer | 53,803 | 0 | 53,803 | 2.5% | 27 Jun, 2024 |
| 15 | Eric Conley | Svp, Orthodontics | 53,223 | 0 | 53,223 | 2.5% | 29 May, 2024 |
| 16 | Vivek Jain | Director | 52,945 | 0 | 52,945 | 2.5% | 21 May, 2026 |
| 17 | Veronica Acurio | President, Orthodontics | 48,806 | 0 | 48,806 | 2.3% | 27 Aug, 2026 |
| 18 | Curt W Bludworth | Chief Human Resources Officer | 46,759 | 0 | 46,759 | 2.2% | 02 Mar, 2022 |
| 19 | Robert Befidi | President, Diagnostics | 45,785 | 0 | 45,785 | 2.2% | 27 Aug, 2026 |
| 20 | Howard H Yu | Chief Financial Officer | 43,900 | 0 | 43,900 | 2.1% | 18 Sep, 2023 |
| 21 | Jeffrey Kappler | Senior Vice President | 37,336 | 0 | 37,336 | 1.8% | 19 Nov, 2021 |
| 22 | Jean-Claude Kyrillos | Senior Vice President | 27,838 | 0 | 27,838 | 1.3% | 28 Feb, 2023 |
| 23 | Mischa Reis | Svp, Strategy Bus. Dev. | 27,321 | 0 | 27,321 | 1.3% | 24 Aug, 2026 |
| 24 | Kari Lyn Moore | Vp Chief Acct. Officer | 25,311 | 0 | 25,311 | 1.2% | 01 Mar, 2022 |
| 25 | James Andrew Pierce | Director | 18,485 | 0 | 18,485 | 0.9% | 21 May, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 25 Aug, 2026 | Robert Befidi | President, Diagnostics | Disposed F | 5,147 | $27.47 | $141.39K | 45,785 | Direct |
| 25 Aug, 2026 | Stefan Nilsson | President, Nobel Biocare | Disposed F | 804 | $27.47 | $22.09K | 61,560 | Direct |
| 25 Aug, 2026 | Eric D. Hammes | Chief Financial Officer | Disposed F | 10,885 | $27.47 | $299.01K | 99,913 | Direct |
| 25 Aug, 2026 | Veronica Acurio | President, Orthodontics | Disposed F | 7,710 | $27.47 | $211.79K | 48,806 | Direct |
| 20 Aug, 2026 | Mischa Reis | Svp, Strategy Bus. Dev. | Disposed S | 8,000 | $27.50 | $220.00K | 27,321 | Direct |
| 18 Aug, 2026 | Eric D. Hammes | Chief Financial Officer | Acquired A | 47,970 | $0.00 | $0 | 47,970 | Direct |
| 18 Aug, 2026 | Paul A Keel | Chief Executive Officer | Acquired A | 179,730 | $0.00 | $0 | 551,304 | Direct |
| 18 Aug, 2026 | Paul A Keel | Chief Executive Officer | Acquired A | 159,900 | $0.00 | $0 | 159,900 | Direct |
| 25 May, 2026 | Paul A Keel | Chief Executive Officer | Disposed F | 12,811 | $23.43 | $300.16K | 371,574 | Direct |
| 19 May, 2026 | Kieran Gallahue | Director | Acquired A | 9,330 | $0.00 | $0 | 54,010 | Direct |
| 19 May, 2026 | Wendy Carruthers | Director | Acquired A | 9,330 | $0.00 | $0 | 59,940 | Direct |
| 19 May, 2026 | Vivek Jain | Director | Acquired A | 9,330 | $0.00 | $0 | 52,945 | Direct |
| 19 May, 2026 | R Scott Huennekens | Director | Acquired A | 12,585 | $0.00 | $0 | 82,105 | Direct |
| 19 May, 2026 | James Andrew Pierce | Director | Acquired A | 9,330 | $0.00 | $0 | 18,485 | Direct |
| 19 May, 2026 | Christine A Tsingos | Director | Acquired A | 9,330 | $0.00 | $0 | 59,930 | Direct |
| 19 May, 2026 | Daniel Raskas | Director | Acquired A | 9,330 | $0.00 | $0 | 54,010 | Direct |
| 25 Feb, 2026 | Mark E Nance | General Counsel | Disposed F | 3,368 | $29.59 | $99.66K | 68,577 | Direct |
| 25 Feb, 2026 | Stefan Nilsson | President, Nobel Biocare | Disposed F | 182 | $29.59 | $5.39K | 54,759 | Direct |
| 25 Feb, 2026 | Eric D. Hammes | Chief Financial Officer | Disposed F | 2,045 | $29.59 | $60.51K | 94,743 | Direct |
| 25 Feb, 2026 | Paul A Keel | Chief Executive Officer | Disposed F | 11,840 | $29.59 | $350.35K | 335,715 | Direct |